PNTG vs. CON, SGRY, PRVA, HTFL, VCYT, CELC, LFST, ADUS, PGNY, and ARDT
Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Celcuity (CELC), LifeStance Health Group (LFST), Addus HomeCare (ADUS), Progyny (PGNY), and Ardent Health (ARDT). These companies are all part of the "healthcare" industry.
The Pennant Group vs. Its Competitors
The Pennant Group (NASDAQ:PNTG) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, media sentiment, profitability, institutional ownership, valuation and earnings.
Concentra Group Holdings Parent has a net margin of 7.44% compared to The Pennant Group's net margin of 3.36%. Concentra Group Holdings Parent's return on equity of 50.84% beat The Pennant Group's return on equity.
The Pennant Group has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Comparatively, Concentra Group Holdings Parent has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.
85.9% of The Pennant Group shares are owned by institutional investors. 5.4% of The Pennant Group shares are owned by company insiders. Comparatively, 6.6% of Concentra Group Holdings Parent shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Concentra Group Holdings Parent had 1 more articles in the media than The Pennant Group. MarketBeat recorded 4 mentions for Concentra Group Holdings Parent and 3 mentions for The Pennant Group. Concentra Group Holdings Parent's average media sentiment score of 1.67 beat The Pennant Group's score of 0.86 indicating that Concentra Group Holdings Parent is being referred to more favorably in the news media.
Concentra Group Holdings Parent has higher revenue and earnings than The Pennant Group. Concentra Group Holdings Parent is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.
The Pennant Group currently has a consensus target price of $34.40, suggesting a potential upside of 39.67%. Concentra Group Holdings Parent has a consensus target price of $27.50, suggesting a potential upside of 28.50%. Given The Pennant Group's higher possible upside, equities analysts clearly believe The Pennant Group is more favorable than Concentra Group Holdings Parent.
Summary
Concentra Group Holdings Parent beats The Pennant Group on 12 of the 16 factors compared between the two stocks.
Get The Pennant Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
The Pennant Group Competitors List
Related Companies and Tools
This page (NASDAQ:PNTG) was last updated on 9/16/2025 by MarketBeat.com Staff